Volume 26, Number 6—June 2020
Research
Characterization of Sporadic Creutzfeldt-Jakob Disease and History of Neurosurgery to Identify Potential Iatrogenic Cases
Table 3
Patient no. | Age at CJD onset, y/sex | Codon 129 of PRNP | Hyperintensity lesions on DW-MRI | Pathology findings |
---|---|---|---|---|
1 | 58/F | MM | CC, BG, Th | MM2+1 |
2 | 65/M | MM | CC, Th | MM2+1 |
3 | 61/F | MM | CC, BG, Th | ND |
4 | 58/M | MV | BG, Th | MV2 |
5 | 73/F | MV | CC, Th | MV2 |
6 | 65/F | MV | CC, BG, Th | ND |
7 | 65/F | MV | CC, Th | ND |
8 | 75/F | VV | BG, Th | VV2 |
9 | 69/M | VV | BG, Th | VV2 |
10 |
52/M |
VV |
CC, BG, Th |
ND |
*BG, basal ganglia; CC, cerebral cortex; CJD, Creutzfeldt-Jakob disease; DW-MRI, diffusion-weighted magnetic resonance imaging; MM, methionine homozygous; MM2+1, pathological features of MM2 and MM1 types of sporadic CJD; MV, methionine-valine; Th, thalamus; VV, valine homozygous. |
Page created: May 18, 2020
Page updated: May 18, 2020
Page reviewed: May 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.